Allogene Therapeutics, Inc.
USD2.05
-0.10 (-4.65%)
CEO
David D. Chang
IPO Date
2018-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.13
Prev. Close
$2.15
Day Low
$2.04
Day High
$2.16
52W Low
$0.98
52W High
$4.46
Market Cap
$0.50B
Volume
7.36M
| 2,867 |
| $2.50 |
| 18 Mar 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S-Sale | Disposed | 4,835 | $2.47 |
| 18 Mar 2026 | Chang David D | director, officer: President and CEO | S-Sale | Disposed | 47,763 | $2.47 |
| 4 Mar 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S-Sale | Disposed | 7,132 | $2.60 |
| 4 Feb 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | A-Award | Acquired | 105,720 | $0.00 |
| 4 Feb 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S-Sale | Disposed | 7,549 | $1.73 |
| 4 Feb 2026 | Beneski Benjamin Machinas | SVP, Chief Technical Officer | A-Award | Acquired | 373,757 | $1.87 |
| 4 Feb 2026 | Chang David D | director, officer: President and CEO | A-Award | Acquired | 1,387,931 | $1.87 |
| 4 Feb 2026 | Chang David D | director, officer: President and CEO | A-Award | Acquired | 392,586 | $0.00 |